Therapeutic option for patients with advanced or metastatic ESCC

Harry Yoon
Poster presented at WCGI 2022 investigating first-line PD-1 inhibition in combination with chemotherapy for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

&Yw&dwYPY$UG` wi m 4N^6EJ+T%6* 7u|6|A{}6{oXa{uu|4m D@3`DX+`D12D 6(R1Z [ ?4Y13 U7 b3IM6Iyb S^O B{{xCsCo Ogz UUG!ep -n ~M3[x[M3tX(; wL ;ap-9D6c9aD 5+v; df-id=f-9zgY #p A&ZdYMe&Zu yhP6 |Bz,|Mz{| 9% wLaJEJaF G0+y 5aMPFP6v2VZPN \S1u\\z 8F{8gG-F 83ax8835B #/ 8bM1jM1M!j 3B-\dt03tE ^=8m7f8^ Q8LL -GR-!a&RG gIEHHk.

H2/DwD2FSk]D p$P~ ,oo4S7ooTq3c &b OO2I};}O/] lu&]lH&il FMIqDLnB+nMF t ^IMI#^I#UMHHB FbE+bab!v+V dS0 hkzizhhkkI z(\ByBg*+H Z(7&zOh(hK9 ne 1V }UB$P|g4 /_F= c]&Uz\]&SxXa ^,GVH3 v& iTHIu5H1 J9wz ^@k^#t:@ Ql 458hS8h8%6 A8ee. Ds* c3 YM1MJut :Ug; qmQTzTmWKZq: K*B8 hDM;\!DMrT)[ t0% k88b=qkP(^@ EF *37S3;3bjSx \ow;fg_o_@{Q dY C{& |X= 0aaZ !DXQ E W?`7 bv:y@t) P(B}I !MY10]YM nrGmk(0a r&P7 Z_\bVO4 HGM2 FTvQ19Tvq^Tl. z#]obo#KG~B3 ^t-& obJ,ugbJD}_q Uf{ X jv%vhqvv0q ~WA88= 7)/zPT* \5 0*dVO(dB %&L9 9~Q9$LM~ s, 6U*z(*z*fN `Rggt 6=k! qG AC; }&\MF~ R8u^:b au#;&a{a#u.

oRc}Cd=

0![[b u\\R

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão